Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

HEPATITIS

Universal screening for hepatitis C virus infection should be linked to universal treatment access

New national hepatitis C virus (HCV) screening guidance from the United States Preventive Services Task Force includes a recommendation for one-time testing for all adults aged 18 to 79 years. Implicit in the new guidance is that all people diagnosed with chronic HCV infection should be offered HCV treatment.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

References

  1. World Health Organization. Global health strategy on viral hepatitis 2016–2021 (WHO, 2016).

  2. Dore, G. J., Martinello, M., Alavi, M. & Grebely, J. Global elimination of hepatitis C virus by 2030: why not? Nat. Med. 26, 157–160 (2020).

    Article  CAS  Google Scholar 

  3. Yehia, B. R., Schranz, A. J., Umscheid, C. A. & Lo Re, V. 3rd. The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis. PLoS One 9, e101554 (2014).

    Article  Google Scholar 

  4. US Preventive Services Task Force. Screening for hepatitis C virus infection in adolescents and adults: US Preventive Services Task Force Recommendation Statement. JAMA https://doi.org/10.1001/jama.2020.1123 (2020).

  5. Dore, G. J. & Hajarizadeh, B. Elimination of hepatitis C virus in Australia: laying the foundation. Infect. Dis. Clin. North Am. 32, 269–279 (2018).

    Article  Google Scholar 

  6. Chou, R. et al. Screening for hepatitis C virus infection in adolescents and adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA https://doi.org/10.1001/jama.2019.20788 (2020).

    Article  Google Scholar 

  7. US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02683005 (2020).

  8. Samuel, S. T., Martinez, A. D., Chen, Y., Markatou, M. & Talal, A. H. Hepatitis C virus knowledge improves hepatitis C virus screening practices among primary care physicians. World J. Hepatol. 10, 319–328 (2018).

    Article  Google Scholar 

  9. Springer, S. A., Merluzzi, A. P. & Del Rio, C. Integrating responses to the opioid use disorder and infectious disease epidemics: a report from the National Academies of Sciences, Engineering, and Medicine. JAMA https://doi.org/10.1001/jama.2020.2559 (2020).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gail V. Matthews.

Ethics declarations

Competing interests

The Kirby Institute is funded by the Australian Government Department of Health and Ageing. The views expressed in this publication do not necessarily represent the position of the Australian Government. G.J.D. is an advisory board member of and has received honoraria from Merck, Gilead Sciences and AbbVie, and has received research grant funding from Merck, Gilead Sciences and AbbVie, as well as travel sponsorship from Merck, Gilead Sciences and AbbVie. G.V.M. has received research grant funding from AbbVie and Gilead Sciences.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Dore, G.J., Matthews, G.V. Universal screening for hepatitis C virus infection should be linked to universal treatment access. Nat Rev Gastroenterol Hepatol 17, 321–322 (2020). https://doi.org/10.1038/s41575-020-0306-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41575-020-0306-8

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing